Read our latest updates from research breakthroughs to government actions to fundraising heroes. You can also read personal stories from women and their families directly affected by ovarian cancer.
Today sees the release of a global study from the World Ovarian Cancer Coalition. Among other things, it shows us that women in the UK are being failed when it comes to early diagnosis of ovarian cancer in comparison with other countries.
Thursday, 13 September saw over 100 women with ovarian cancer and their family and friends join specialist doctors, surgeons, and researchers for Target Ovarian Cancer’s third Ask the Experts Conference at the University of Reading.
This September we’re going to TAKE OVAR and come together as friends and musicians to raise awareness and funds for Target Ovarian Cancer, in memory of my friend Katie.
Her Royal Highness The Duchess of Cornwall visits women with ovarian cancer and their families in Scotland to mark 10 years of Target Ovarian Cancer.
Join us and raise awareness of ovarian cancer this September for Gynaecological Cancer Awareness Month.
Target Ovarian Cancer is delighted to announce the appointment of a new leadership role in the charity of Director Emeritus.
Today sees the launch of a pilot NHS ovarian cancer early detection service aimed at women with the BRCA mutation.
After becoming available in England and Wales in June, gamechanging new ovarian cancer drug niraparib (Zejula®) was today approved by the Scottish Medicines Consortium (SMC).
Elaine is training to run a 10K for her mum who was diagnosed in 2016, and in memory of her mum’s friend Glenda.
Sign up to receive emails from Target Ovarian Cancer, including our monthly newsletter, and be the first to hear about campaigns, upcoming events and fundraising inspiration.
Sign up
